General ENT News

ENT

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lee YJ et al. - The authors demonstrated weekly 5-FU-cisplatin with conventional radiotherapy was efficacious and feasible with high compliance rate in locally advanced head and neck cancer.

 

Related Articles

Planned neck dissection following primary chemoradiation for advanced-stage head and neck cancer
Otolaryngology Head and Neck Surgery, 10/13/09    Relevance Score: 71%

Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk
International Journal of Epidemiology, 10/08/09    Relevance Score: 71%

Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09    Relevance Score: 69%

Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09    Relevance Score: 69%

Progesterone receptors identified in vascular malformations of the head and neck
Otolaryngology Head and Neck Surgery, 10/09/09    Relevance Score: 69%

Today in Clinical Pharmacology...keeping you current

Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis
Allergy and Asthma Proceedings, 12/17/09

Single dose of preoperative analgesia with gabapentin (600 mg) is safe and effective in monitored anesthesia care for nasal surgery
European Archives of Oto-Rhino-Laryngology, 12/16/09

The shelf life of antimicrobial ear drops
The Laryngoscope, 12/15/09

Today in Head and Neck...keeping you current

Secondary surgery in paediatric facial paralysis reanimation
Journal of Plastic, Reconstructive & Aesthetic Surgery, 12/18/09

Dizziness and vertigo in an older population: the Blue Mountains prospective cross-sectional study
Clinical Otolaryngology, 12/18/09

When will I see you again? Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients
Clinical Otolaryngology, 12/18/09